rs151318611

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_032382.5(COG8):​c.5C>T​(p.Ala2Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,608,912 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A2A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 4 hom. )

Consequence

COG8
NM_032382.5 missense

Scores

1
4
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 1.61

Publications

5 publications found
Variant links:
Genes affected
COG8 (HGNC:18623): (component of oligomeric golgi complex 8) This gene encodes a protein that is a component of the conserved oligomeric Golgi (COG) complex, a multiprotein complex that plays a structural role in the Golgi apparatus, and is involved in intracellular membrane trafficking and glycoprotein modification. Mutations in this gene cause congenital disorder of glycosylation, type IIh, a disease that is characterized by under-glycosylated serum proteins, and whose symptoms include severe psychomotor retardation, failure to thrive, seizures, and dairy and wheat product intolerance. [provided by RefSeq, Jul 2008]
NIP7 (HGNC:24328): (nucleolar pre-rRNA processing protein NIP7) Enables RNA binding activity. Predicted to be involved in ribosomal large subunit biogenesis. Located in cytosol; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035721958).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000847 (129/152330) while in subpopulation NFE AF = 0.00148 (101/68028). AF 95% confidence interval is 0.00125. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032382.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COG8
NM_032382.5
MANE Select
c.5C>Tp.Ala2Val
missense
Exon 1 of 6NP_115758.3
COG8
NM_001379261.1
c.5C>Tp.Ala2Val
missense
Exon 1 of 7NP_001366190.1
COG8
NM_001379262.1
c.5C>Tp.Ala2Val
missense
Exon 1 of 6NP_001366191.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COG8
ENST00000306875.10
TSL:1 MANE Select
c.5C>Tp.Ala2Val
missense
Exon 1 of 6ENSP00000305459.6Q96MW5
ENSG00000260371
ENST00000563634.1
TSL:4
c.3-2836C>T
intron
N/AENSP00000454500.1H3BMQ9
ENSG00000259900
ENST00000564737.1
TSL:5
n.466-2836C>T
intron
N/AENSP00000462747.1J3KT08

Frequencies

GnomAD3 genomes
AF:
0.000848
AC:
129
AN:
152212
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00148
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000831
AC:
205
AN:
246564
AF XY:
0.000910
show subpopulations
Gnomad AFR exome
AF:
0.000189
Gnomad AMR exome
AF:
0.000378
Gnomad ASJ exome
AF:
0.000499
Gnomad EAS exome
AF:
0.0000550
Gnomad FIN exome
AF:
0.000930
Gnomad NFE exome
AF:
0.00138
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00117
AC:
1705
AN:
1456582
Hom.:
4
Cov.:
32
AF XY:
0.00117
AC XY:
850
AN XY:
724770
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33414
American (AMR)
AF:
0.000514
AC:
23
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.0000813
AC:
7
AN:
86150
European-Finnish (FIN)
AF:
0.000896
AC:
45
AN:
50208
Middle Eastern (MID)
AF:
0.000720
AC:
3
AN:
4168
European-Non Finnish (NFE)
AF:
0.00141
AC:
1568
AN:
1111932
Other (OTH)
AF:
0.000731
AC:
44
AN:
60186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
97
193
290
386
483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000847
AC:
129
AN:
152330
Hom.:
0
Cov.:
32
AF XY:
0.000738
AC XY:
55
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41570
American (AMR)
AF:
0.000457
AC:
7
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00148
AC:
101
AN:
68028
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00124
Hom.:
0
Bravo
AF:
0.000703
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000882
AC:
107
EpiCase
AF:
0.00115
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
COG8-congenital disorder of glycosylation (3)
-
3
-
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0098
T
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.036
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
0.69
N
PhyloP100
1.6
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
0.010
N
REVEL
Benign
0.12
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.070
T
Polyphen
0.98
D
Vest4
0.53
MVP
0.65
MPC
0.93
ClinPred
0.074
T
GERP RS
5.2
PromoterAI
-0.39
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.25
gMVP
0.62
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151318611; hg19: chr16-69373451; COSMIC: COSV54741607; COSMIC: COSV54741607; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.